Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (56)
- Committees and advisory bodies (45)
- Safety monitoring and information (12)
- Advertising (9)
- Manufacturing (9)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Clinical trials (3)
- Legislation (3)
- Medicinal cannabis hub (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
247 result(s) found, displaying 101 to 125
-
Corporate reportsThe Australian Government remains committed to the safety, health and wellbeing of all Australians.
-
Corporate reportsHighlights and Achievements from the International Engagement Strategy 2016-2020
-
-
-
Corporate reportsThese guidelines apply to company-sponsored post-marketing surveillance studies of drug safety and toxicity
-
Corporate reportsAdvancing Australia's health through international regulatory engagement
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 3 February 2021
-
Corporate reportsThe PVIP aims to strengthen and broaden the TGA's post-market monitoring activities and protect public health
-
Corporate reportsRead our clinician information sheet on opioid analgesic tapering.
-
-
Corporate reportsThe July-December 2020 Half Yearly Performance Statistics Report is now available
-
Corporate reportsThe Australian Government has accepted all 22 recommendations
-
Corporate reportsGuidance for procurement areas in hospitals, aged care residential facilities and other facilities.
-
-
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard published on 26 August 2020
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 9 September 2020
-
Corporate reportsTargets have been met for the measures under the six KPIs
-
Scheduling submissionsPublic submissions made in response to the interim decision on nicotine scheduling published on 23 September 2020
-
Corporate reportsProposal to prevent the uptake of nicotine containing e-cigarettes by ever users (adolescents and young adults), to support smoking cessation and to reduce nicotine poisonings of children
-
Corporate reportsInsights into therapeutic goods safety regulatory activity for our recalls program.
-
Corporate reportsInsights into manufacturing quality regulatory activity.
-
Corporate reportsThe TGA has published insights into recalls and GMP regulation for 2019-20.
-
Corporate reportsResults of communication developmental research undertaken to inform consumer and health professional communication activities for the opioid regulatory reforms.
-
Corporate reportsRead our clinician information sheet on opioid analgesic tapering: summary.